RQ Bio
Biotech developing long-acting monoclonal antibodies to prevent seasonal flu and other respiratory viruses.
↗Why it's here
Raised an oversubscribed $115M Series A led by Frazier Life Sciences in June 2026.
source: uk.finance.yahoo.com- Focus
- Antibody Therapeutics
- Founded
- 2021
- Registered office
- Scale Space, 58 Wood Lane, Hammersmith and Fulham W12 7RZsource: find-and-update.company-information.service.gov.uk
- London presence
- HQsource: find-and-update.company-information.service.gov.uk
- Investors
- Frazier Life Sciences (lead), EQT Life Sciences, Forbion, LifeArc Ventures, Monograph Capital, Oxford Science Enterprises, Wellington Managementsource: uk.finance.yahoo.com
- Nearest station
- White City, 250 m
- Visas
- Licensed visa sponsor, listed as RQ Biotechnology Limitedsource: gov.uk
Verified 6 Oct 2026. How we verify · Suggest a fix